Trial intelligence / Profile preview

PAPA Pilot: Postoperative Antibiotics in Perforated Appendicitis

NCT07656636Not yet recruiting

Start
Jan 2027
Primary completion
Jan 2028
01

Overview

Randomised, open-label trial in perforated appendicitis (2 arms). Primary endpoints: Average number of participants enrolled per month at 1 year, Percentage of participants who receive the correct intervention at 1 year and 1 more. Planned start Jan 2027; status: not yet recruiting.

02

Conditions

perforated appendicitis

Beyond the preview

Go deeper on NCT07656636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07656636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call